Skip to content

Author

P. Calabrò

We have 3 of 435 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Nov 2026

Prognostic Impact of Paravalvular Regurgitation in Patients With Severe Low-Flow, Low-Gradient Aortic Stenosis Undergoing TAVR.

BACKGROUND Paravalvular regurgitation (PVR) is a frequent complication after transcatheter aortic valve replacement (TAVR) and may influence clinical outcomes in patients with high-gradient aortic stenosis. However, its prognostic relevance in patients with low-flow, low-gradient aortic stenosis (LFLG-AS) undergoing TA...

M. Bellino, A. Silverio, G. Ferruzzi et al. · 1 citation
Review Open access Sep 2026

Personalised antiplatelet therapy during elective percutaneous coronary intervention in patients with chronic coronary syndrome: An international journal of cardiology expert consensus statement.

Oral P2Y12 inhibitors represent the mainstay therapy for the prevention of thrombotic complications in patients undergoing percutaneous coronary intervention (PCI) and coronary stent implantation. However, the onset of antiplatelet action of the oral P2Y12 inhibitors is affected by their need to be absorbed in the gast...

F. Pelliccia, Giuseppe Andò, P. Capranzano et al. · 0 citations
Aug 2026

Cangrelor in elderly patients undergoing percutaneous coronary intervention: findings from the ICARUS Registry.

Elderly patients were at higher risk of NACE, driven by an increased risk of both ischemic and bleeding events, the latter including access-site and nonaccess-site hemorrhages of both minor and major severity.

S. Benenati, F. Gragnano, Sebastiano Stratoti et al. · 1 citation

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.